The risk of death from cardiovascular causes, nonfatal stroke, or nonfatal myocardial infarction (the first key secondary end point) was 15% lower with bempedoic acid than with placebo, and the. Check spelling or type a new query. Nexletol (bempedoic acid) is an oral tablet for high cholesterol that may be used to lower the risk of heart attack and heart procedures (for example stent placement or bypass surgery), in adults not taking a statin who have known heart disease or are at
New data for esperion’s cholesterol lowering daily pill nexletol, used when statins are not working in people at risk of a heart attack, could inject some momentum into the drug’s slow rollout. We did not find results for Oral bempedoic acid (nexletol® in the usa
A 2023 study found that compared with a placebo, bempedoic acid can lower the risk of heart attacks and related problems. 5, 8, 7 the american college of cardiology. The fda has approved broad new label expansions for bempedoic acid (nexletol Esperion therapeutics, inc) to reduce the risk of myocardial infarction and coronary revascularization in adults with established cardiovascular disease (cvd) or a high risk for a cvd event who are unable to use statin therapy
The medication is also approved as an adjunct to diet, alone or in combination with other.
